Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Vergleich von PPV und LVOT VTI während passiver Beinhebung zur Vorhersage der Volumenreagibilität

3. November 2026 aktualisiert von: Ahmet Salih Tüzen, MD, Izmir Katip Celebi University

Vergleich von Pulsdruckvariation und LVOT-VTI-basierten Herzzeitvolumenänderungen während passiver Beinhebung zur Vorhersage von Volumenreagibilität bei mechanisch beatmeten kritisch kranken Patienten: Eine prospektive Beobachtungsstudie

Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.

The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.

The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.

Studienübersicht

Status

Rekrutierung

Bedingungen

Detaillierte Beschreibung

This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.

In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.

In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.

Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:

  • Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
  • Non-fluid responsive: Patients showing <10% change in LVOT VTI-based CO following PLR

After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.

The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.

The recorded data will include:

  • Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
  • Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
  • Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database

Informed consent will be obtained from all participating patients or their legally authorized representatives.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

48

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Ahmet Salih Tüzen, M.D.
  • Telefonnummer: +90 535 391 55 77
  • E-Mail: astuzen@icloud.com

Studieren Sie die Kontaktsicherung

Studienorte

      • Izmir, Türkei (türkiye)
        • Rekrutierung
        • Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

The study population consists of adult critically ill patients admitted to the Intensive Care Unit (ICU) who are receiving mechanical ventilation support. Eligible participants are those identified by the intensive care team as having a suspected intravascular fluid deficit, for whom a fluid responsiveness assessment is clinically indicated. The cohort specifically targets patients undergoing the Passive Leg Raising (PLR) maneuver as part of routine standard practice, where invasive arterial monitoring is available to record Pulse Pressure Variation (PPV).

Beschreibung

Inclusion Criteria:

  1. Adult patients aged ≥18 years
  2. Patients admitted to the intensive care unit receiving mechanical ventilation
  3. Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
  4. Patients in sinus rhythm
  5. Presence of invasive arterial blood pressure monitoring
  6. Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
  7. Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
  8. Hemodynamically stable enough to allow measurement

Exclusion Criteria:

  1. Patients under 18 years of age
  2. Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
  3. Severe right ventricular dysfunction or significant tricuspid regurgitation
  4. Advanced aortic valve disease (severe stenosis or severe regurgitation)
  5. Patients with significant spontaneous breathing effort
  6. Patients receiving lung-protective low tidal volume ventilation strategy (<8 mL/kg) due to ARDS
  7. Inadequate echocardiographic window for LVOT VTI assessment
  8. Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
  9. Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: COHORT
  • Zeitperspektiven: PROSPECTIVE

Kohorten und Interventionen

Gruppe / Kohorte
Fluid Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline.

Fluid Non-Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of < 10% from baseline.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Pulse Pressure Variation (Delta PPV)
Zeitfenster: Baseline (T0) and between 60 seconds after the PLR maneuver.

Pulse Pressure Variation (PPV) is recorded via invasive arterial monitoring at baseline (T0, semi-sitting) and during the Passive Leg Raising maneuver (T1).

Baseline (T0) and between 60 seconds after the PLR maneuver.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentage Change in Cardiac Output (Delta CO)
Zeitfenster: Baseline (T0) and between 60 seconds after the PLR maneuver.

Cardiac Output (CO) is calculated using the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) and the LVOT diameter measured via transthoracic echocardiography.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Correlation between Delta PPV and Delta CO
Zeitfenster: Baseline (T0) and between 60 seconds after the PLR maneuver.

Correlation Coefficient (r) between PPV Change and Cardiac Output Change

Baseline (T0) and between 60 seconds after the PLR maneuver.
Hemodynamic Parameter Changes (MAP, HR)
Zeitfenster: Baseline (T0) and between 60 seconds after the PLR maneuver.

Measurement of changes in mean arterial pressure and heart rate before and after PLR and comparison between groups.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Diagnostic Accuracy (ROC-AUC, Sensitivity, Specificity, Cut-off)
Zeitfenster: Baseline (T0) and between 60 seconds after the PLR maneuver.

Evaluation of diagnostic performance of ΔPPV and ΔCO using receiver operating characteristic (ROC) analysis, including AUC, optimal cut-off value, sensitivity, and specificity for predicting fluid responsiveness.

Baseline (T0) and between 60 seconds after the PLR maneuver.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Murat Aksun, Izmir Katip Celebi University Atatürk Training and Research Hospital

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Januar 2026

Primärer Abschluss (Geschätzt)

1. Januar 2027

Studienabschluss (Geschätzt)

1. Juni 2027

Studienanmeldedaten

Zuerst eingereicht

13. Dezember 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. Dezember 2025

Zuerst gepostet (Tatsächlich)

26. Dezember 2025

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

4. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

3. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2025-SAEK-0811

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Beschreibung des IPD-Plans

All data necessary to support the study protocol, including de-identified individual participant data (IPD) related to study protocol, and primary and secondary outcome measures, will be made available upon reasonable request from qualified researchers for academic purposes, in accordance with institutional and ethical guidelines.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .